"Influenza B virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Species of the genus INFLUENZAVIRUS B that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed.
MeSH Number(s)
B04.820.545.407.410
B04.909.777.545.407.410
Concept/Terms
Influenza B virus- Influenza B virus
- Influenza B viruses
- Orthomyxoviruses Type B
- Influenza Viruses Type B
Below are MeSH descriptors whose meaning is more general than "Influenza B virus".
Below are MeSH descriptors whose meaning is more specific than "Influenza B virus".
This graph shows the total number of publications written about "Influenza B virus" by people in Harvard Catalyst Profiles by year, and whether "Influenza B virus" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 3 | 1 | 4 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 2 | 1 | 3 |
| 2020 | 3 | 1 | 4 |
| 2021 | 1 | 2 | 3 |
| 2022 | 1 | 3 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Influenza B virus" by people in Profiles.
-
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clin Infect Dis. 2024 Apr 10; 78(4):1056-1064.
-
Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin. Proc Natl Acad Sci U S A. 2024 Jan 02; 121(1):e2316964120.
-
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial. Vaccine. 2023 04 17; 41(16):2716-2722.
-
Infant Antibody Repertoires during the First Two Years of Influenza Vaccination. mBio. 2022 12 20; 13(6):e0254622.
-
Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in Children. J Infect Dis. 2022 09 21; 226(6):1022-1026.
-
Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children. Clin Infect Dis. 2022 08 25; 75(2):230-238.
-
A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection. Viruses. 2022 06 14; 14(6).
-
Development of functional antibodies against influenza B virus by activation-induced cytidine deaminase in hybridoma cells. Virol Sin. 2022 Aug; 37(4):619-622.
-
Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus. Diagn Microbiol Infect Dis. 2022 Feb; 102(2):115575.
-
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study. Clin Infect Dis. 2021 10 20; 73(8):1459-1468.